Yes, as mentioned in the product datasheet, the powder form should be stored at –20°C. Stock solutions may be prepared at 100 mg/mL in DMEM/F12 or other culture medium, and stored at –20°C in frozen aliquots. Avoid repeated freeze/thaw cycles. Please see the link below to review the product datasheet for additional information:
https://www.sigmaaldrich.com/deepweb/assets/sigmaaldrich/product/documents/173/127/c2139pis.pdf
Przejdź do
Wybierz wielkość
| Gabaryty przesyłki | SKU | Dostępność | Cena netto |
|---|---|---|---|
| 100 mg | Skontaktuj się z Obsługą Klienta, aby uzyskać informacje na temat dostępności | 529,00 zł | |
| 500 mg | Skontaktuj się z Obsługą Klienta, aby uzyskać informacje na temat dostępności | 1760,00 zł | |
| 1 g | Skontaktuj się z Obsługą Klienta, aby uzyskać informacje na temat dostępności | 2660,00 zł | |
| 5 g | Skontaktuj się z Obsługą Klienta, aby uzyskać informacje na temat dostępności | 10 550,00 zł |
Informacje o tej pozycji
529,00 zł
biological source
Clostridium histolyticum
Quality Level
type
Type VIII
form
powder
specific activity
≥125 CDU/mg solid, 0.5-5.0 FALGPA units/mg solid
mol wt
68-125 kDa
suitability
suitable for release of rat epididymal adipocytes and hepatocytes (for methodology see Type II and Type IV)
application(s)
diagnostic assay manufacturing
storage temp.
−20°C
General description
Application
- for the preparation of arterial tissue for the study of advanced glycosylation end products (AGE)
- for use along with other proteases for the disaggregation of human tumor, mouse kidney, human brain, lung epithelium and many other tissues.
- in liver and kidney perfusion studies, digestion of pancreas, and isolation of nonparenchymal hepatocytes.
- for the preparation of viable hepatocytes from rat liver and for the isolation of fat cells from rat adipose tissue
Biochem/physiol Actions
Analysis Note
Other Notes
1 of 1
Ta pozycja | |||
|---|---|---|---|
| biological source Clostridium histolyticum | biological source Clostridium histolyticum | biological source - | biological source - |
| specific activity ≥125 CDU/mg solid, 0.5-5.0 FALGPA units/mg solid | specific activity ≥125 CDU/mg solid, 0.5-5.0 FALGPA units/mg solid | specific activity ≥125 CDU/mg solid, 0.5-5.0 FALGPA units/mg solid | specific activity ≥1 FALGPA units/mg solid, >125 CDU/mg solid |
| suitability suitable for release of rat epididymal adipocytes and hepatocytes (for methodology see Type II and Type IV) | suitability - | suitability suitable for release of physiologically active rat hepatocytes | suitability - |
| form powder | form powder | form powder | form powder |
| application(s) diagnostic assay manufacturing | application(s) diagnostic assay manufacturing | application(s) diagnostic assay manufacturing | application(s) diagnostic assay manufacturing |
| storage temp. −20°C | storage temp. −20°C | storage temp. −20°C | storage temp. −20°C |
signalword
Danger
hcodes
Hazard Classifications
Eye Irrit. 2 - Resp. Sens. 1 - Skin Irrit. 2 - STOT SE 3
target_organs
Respiratory system
Klasa składowania
11 - Combustible Solids
wgk
WGK 1
flash_point_f
Not applicable
flash_point_c
Not applicable
ppe
dust mask type N95 (US), Eyeshields, Faceshields, Gloves
Wybierz jedną z najnowszych wersji:
Masz już ten produkt?
Dokumenty związane z niedawno zakupionymi produktami zostały zamieszczone w Bibliotece dokumentów.
Protokoły
To measure collagenase activity, N-(3-[2-Furyl]acryloyl)-Leu-Gly-Pro-Ala is used in a continuous spectrophotometric rate determination at 345 nm. Collagenase hydrolyzes collagen peptide bonds.
Powiązane treści
Instructions
Numer pozycji handlu globalnego
| SKU | NUMER GTIN |
|---|---|
| C2139-1G | 04061833475188 |
| C2139-100MG | 04061833475171 |
| C2139-500MG | 04061833475195 |
| C2139-5G | 04061833475201 |
-
Can I use C2139 to make collagenase solution with medium, and then store it at -20?
1 answer-
Helpful?
-
-
is C2139 sterile ?
1 answer-
Product C2139 is not sterile.
Helpful?
-


